Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Edwards' Inspiris Resilia Valve Receives FDA Approval

IRVINE, Calif., July 5, 2017 – Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received U.S. Food and Drug Administration (FDA) approval for its INSPIRIS RESILIA aortic valve, the first in a new class of resilient heart valves.

3D-printed models could predict leakage location, severity in TAVR

New manufacturing methods can further personalize medicine—and now 3D printing may offer cardiologists a method of testing transcatheter aortic valve replacements (TAVR) for leakage before implantation.

Thumbnail

Early placement of Abiomed's Impella 2.5 increases survival rate in cardiogenic shock patients

New research on a heart pump designed to treat cardiogenic shock patients receiving a percutaneous coronary intervention (PCI) suggests that early placement of the device can boost survival rates.

Thumbnail

Adjunctive Diagnostics in the Cath Lab: Will Value-based Economics Tip the Scale?

Why has the uptake of adjunctive diagnostic procedures like FFR, IVUS and OCT been slow? On the other hand, is there really a need for interventionalists to move beyond angiographic guidance?

Arizona hospital tests new mitral valve procedure that avoids open heart surgery

Physicians at HonorHealth in Scottsdale, Arizona, have implanted a mitral valve in an elderly patient while her heart was still beating, a new approach that’s less invasive, reports the Phoenix Business Journal.

Thumbnail

TVT2017: Experimental transcatheter device yields consistent, positive outcomes for patients

An experimental transcatheter device by Canada-based Neovasc, used to treat mitral regurgitation, was shown to be effective in treating a patient with several severe heart conditions.

Thumbnail

Bacteria in open-heart surgery device more common than scientists thought

A new study presented this week at a global conference in Portland, Oregon, revealed that a significant number of heater-cooler units tested positive for bacteria associated with fatal infections in open-heart surgery patients.

Thumbnail

Blacks with MI have higher mortality rates after ambulance diversion

Plenty of research has been devoted to examining disparities in outcomes for racial minorities. A new study, published in the June issue of Health Affairs, examined the role of emergency department (ED) crowding and ambulance diversion for blacks and whites experiencing MI.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.